Top compounds associated with response to TST


Feature Type Standardized
Nominal ANOVA
mRNA niclosamide CTRPv2 pan-cancer AAC -0.22 2e-08
mRNA RITA CTRPv2 pan-cancer AAC 0.22 3e-08
mRNA 17-AAG CCLE pan-cancer AAC 0.26 7e-08
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-07
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-07
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.17 2e-06
Download CSV